检索结果-南通市图书馆

Hyperoside Suppresses Lipopolysaccharide-induced Inflammation and Apoptosis in human umbilical Vein Endothelial cells

引用

Current Medical Science 2018年第2期38卷 222-228页

作者： Yan-qiang ZHOU Yin-tao ZHAO Xiao-yan ZHAO Cui LIANG Ya-wei XU Ling LI Yuan LIU Hai-bo YANG Department of Cardiology the First Affiliated Hospital of Zhengzhou University Henan 450052 China

Finding the novel drug from the effective components of traditional Chinese herbal medicine is a hotspot of the modem pharmacological research. Hyperoside （HYP） belongs to flavonoid glycosides, and it has various properties, such as anti-inflammation, anti-spasm, anti-diuretic, antitussive, lowering blood pressure, and lowering cholesterol effects as well as protective effects for the cardiac and cerebral blood vessels. The purpose of this study was to investigate the effects of HYP on inflammatory and apoptotic responses in vascular endothelial cells stimulated by lipopolysaccharide （LPS） and further to identify the possible mechanisms underlying these effects. In our study, human umbilical vein endothelial cells （HUVECs） were stimulated with 1 Bg/mL LPS in the presence or absence of HYP （10, 20 and 50 μmol/L）. Our results indicated that HYP alone exerted no cytotoxicity on HUVECs, while it had an upregulatory effect on the viability of HUVECs induced by LPS in a dose-dependent manner; increased mRNA expression of IL-1β, IL-6, TNFα and iNOS induced by LPS was attenuated after treatment with HYP both in a dose- and time-dependent manner; LPS-induced HUVECs apoptosis and cleaved-caspase 8, 9, 3 were all significantly reduced by HYP. Furthermore, the possible pathway involved in apoptosis and inflammation by HYP was detected, and the results showed that when treated with HYP, LPS-induced mitochondrial membrane instability was significantly inhibited through up-regulation of Bcl-2 and down-regulation of Bax. Furthermore, the expression of TLR4 and the phosphorylation of IκBα and p65 in LPS-treated cells were blocked by HYP. Our results suggested that HYP treatment prevented HUVECs from LPS- induced inflammation and apoptosis responses, which might be mediated by inhibiting TLR4/ NFκB pathway.

关键词： hyperoside lipopolysaccharide inflammation apoptosis human umbilical veinendothelial cells

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Bear Bile Powder Inhibits Angiogenesis In Vivo and In Vitro

引用

Chinese Journal of Integrative Medicine 2015年第5期21卷 369-375页

作者：赵锦燕林薇庄群川钟晓勇彭军洪振丰 Fujian Academy of Integrative Medicine Fujian Key Laboratory of Integrative Medicine on Geriatrics Fujian University of Traditional Chinese Medicine

Objective： To evaluate the effect of bear bile powder （BBP） on angiogenesis, and investigate the underlying molecular mechanisms. Methods： A chick embryo chorioallantoic membrane （CAM） assay was used to evaluate the angiogensis in vivo. human umbilical vein endothelial cells （HUVECs） were treated with 0, 0.25, 0.5, 0.75, and 1.0 mg/mL of BBP for 24, 48 and 72 h, respectively. The 3-（4, 5-dimethylthiazol-2-yl）-2,5- diphenyltetrazolium bromide assay was performed to determine the viability of HUVECs. Ceil cycle progression of HUVECs was examined by fluorescence-activated cell sorting （FACS） analysis with propidium iodide staining. HUVEC migration was determined by wound healing method. An ECMatrix gel system was used to evaluate the tube formation of HUVECs. The mRNA and protein expression of vascular endothelial growth factor （VEGF）-A in both HUVECs and HepG2 human cells were examined by reverse transcription-polymerase chain reaction and enzyme linked immunosorbent assay, respectively. ]Results： Compared with the untreated group, BBP inhibited angiogenesis in vivo in the CAM model （P〈0.01）. In addition, treatment with 0.25-1 mg/mL of BBP for 24, 48, or 72 h respectively reduced cell viability by 14%-27%, 29%-69% and 33%-91%, compared with the untreated control cells （P〈0.01）. Additionally, BBP inhibited the proliferation of HUVECs via blocking the cell cycle G1 to S progression, compared with the S phase of untreated cells 48.05% ± 5.00%, 0.25-0.75 mg/mL BBP reduced S phase to 40.38% ± 5.30%, 36.54 ±4.50% and 32.13 ± 3.50%, respectively （P〈0.05）. Moreover, BBP inhibited the migration and tube formation of HUVECs, compared with the tube length of untreated cells 100%± 12%, 0.25-0.75 mg/mL BBP reduced the tube length to 62% ± 9%, 43% ± 5% and 17% ± 3%, respectively （P〈0.01）. Furthermore, BBP treatment down-regulated the mRNA and protein expression levels of VEGF-A in both HepG2 cells and HUVECs. Conclusion： BBP could inhibit the angiogenesis by reducing VEGF-A express

关键词： bear bile powder hepatocellular carcinoma tumor angiogenesis human umbilical veinendothelial cells Chinese medicine

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：